Non-Invasive Liquid Biopsy Market Size, Top Share, Global Trends, Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Non-Invasive Liquid Biopsy Market Size Analysis

Global Non-Invasive Liquid Biopsy Market Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Product
  1. By Value
3. Services
  1. By Value
By Sample
1. Introduction
  1. Sample By Value
2. Stool
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction
  1. By Value
3. Sequencing
  1. By Value
4. Microarray
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Reproductive Health
  1. By Value
4. Metabolic Disorders
  1. By Value
5. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Others
  1. By Value

North America Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Product
  1. By Value
3. Services
  1. By Value
By Sample
1. Introduction
  1. Sample By Value
2. Stool
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction
  1. By Value
3. Sequencing
  1. By Value
4. Microarray
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Reproductive Health
  1. By Value
4. Metabolic Disorders
  1. By Value
5. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Others
  1. By Value
U.S.
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Product
    1. By Value
  3. Services
    1. By Value
2. By Sample
  1. Introduction
    1. Sample By Value
  2. Stool
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction
    1. By Value
  3. Sequencing
    1. By Value
  4. Microarray
    1. By Value
  5. Others
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Reproductive Health
    1. By Value
  4. Metabolic Disorders
    1. By Value
  5. Others
    1. By Value
5. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Product
  1. By Value
3. Services
  1. By Value
By Sample
1. Introduction
  1. Sample By Value
2. Stool
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction
  1. By Value
3. Sequencing
  1. By Value
4. Microarray
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Reproductive Health
  1. By Value
4. Metabolic Disorders
  1. By Value
5. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Others
  1. By Value
U.K.
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Product
    1. By Value
  3. Services
    1. By Value
2. By Sample
  1. Introduction
    1. Sample By Value
  2. Stool
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction
    1. By Value
  3. Sequencing
    1. By Value
  4. Microarray
    1. By Value
  5. Others
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Reproductive Health
    1. By Value
  4. Metabolic Disorders
    1. By Value
  5. Others
    1. By Value
5. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Product
  1. By Value
3. Services
  1. By Value
By Sample
1. Introduction
  1. Sample By Value
2. Stool
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction
  1. By Value
3. Sequencing
  1. By Value
4. Microarray
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Reproductive Health
  1. By Value
4. Metabolic Disorders
  1. By Value
5. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Others
  1. By Value
China
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Product
    1. By Value
  3. Services
    1. By Value
2. By Sample
  1. Introduction
    1. Sample By Value
  2. Stool
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction
    1. By Value
  3. Sequencing
    1. By Value
  4. Microarray
    1. By Value
  5. Others
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Reproductive Health
    1. By Value
  4. Metabolic Disorders
    1. By Value
  5. Others
    1. By Value
5. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Product
  1. By Value
3. Services
  1. By Value
By Sample
1. Introduction
  1. Sample By Value
2. Stool
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction
  1. By Value
3. Sequencing
  1. By Value
4. Microarray
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Reproductive Health
  1. By Value
4. Metabolic Disorders
  1. By Value
5. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Others
  1. By Value
UAE
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Product
    1. By Value
  3. Services
    1. By Value
2. By Sample
  1. Introduction
    1. Sample By Value
  2. Stool
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction
    1. By Value
  3. Sequencing
    1. By Value
  4. Microarray
    1. By Value
  5. Others
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Reproductive Health
    1. By Value
  4. Metabolic Disorders
    1. By Value
  5. Others
    1. By Value
5. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Offering
1. Introduction
  1. Offering By Value
2. Product
  1. By Value
3. Services
  1. By Value
By Sample
1. Introduction
  1. Sample By Value
2. Stool
  1. By Value
3. Urine
  1. By Value
4. Saliva
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Polymerase Chain Reaction
  1. By Value
3. Sequencing
  1. By Value
4. Microarray
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Reproductive Health
  1. By Value
4. Metabolic Disorders
  1. By Value
5. Others
  1. By Value
By End-Users
1. Introduction
  1. End-Users By Value
2. Hospitals and Diagnostic Laboratories
  1. By Value
3. Academic and Research Institutions
  1. By Value
4. Others
  1. By Value
Brazil
1. By Offering
  1. Introduction
    1. Offering By Value
  2. Product
    1. By Value
  3. Services
    1. By Value
2. By Sample
  1. Introduction
    1. Sample By Value
  2. Stool
    1. By Value
  3. Urine
    1. By Value
  4. Saliva
    1. By Value
  5. Others
    1. By Value
3. By Technology
  1. Introduction
    1. Technology By Value
  2. Polymerase Chain Reaction
    1. By Value
  3. Sequencing
    1. By Value
  4. Microarray
    1. By Value
  5. Others
    1. By Value
4. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Reproductive Health
    1. By Value
  4. Metabolic Disorders
    1. By Value
  5. Others
    1. By Value
5. By End-Users
  1. Introduction
    1. End-Users By Value
  2. Hospitals and Diagnostic Laboratories
    1. By Value
  3. Academic and Research Institutions
    1. By Value
  4. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Non-Invasive Liquid Biopsy Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Bio-Techne Corporation
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Exact Sciences Corporation
Thermo Fisher Scientific Inc.
QIAGEN N.V.
MDxHealth
Lonza Group AG
PerkinElmer Inc.
Merck KGaA
OraSure Technologies Inc.
Norgen Biotek Corp
Zymo Research Corporation
Oasis Diagnostics Corporation

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment